Novo Holdings A/S’s Disc Medicine IRON Stock Holding History

Novo Holdings A/S’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,090,772	Closed	-$51.2M	–	38
2023 Q3	$51.2M	Hold	1,090,772	–	–	3.79%	8
2023 Q2	$48.4M	Sell	1,090,772 -1,250,000	-53%	-$44.4M	3.74%	7
2023 Q1	$49.6M	Hold	2,340,772	–	–	3.27%	11
2022 Q4	$46.6M	Buy	+2,340,772	New	+$117M	2.91%	13

Other funds holding IRON

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Novo Holdings A/S's IRON Position: Q4 2023 in Review

Novo Holdings A/S sold out of Disc Medicine (IRON) in Q4 2023, closing a stake of 1,090,772 shares — an estimated $51.2M sold.

Novo Holdings A/S first reported a position in IRON in Q4 2022 and held it in 4 quarters. The position peaked at $51.2M in Q3 2023. 112 funds tracked by Wall St. Rank hold IRON as of Q4 2023.

Novo Holdings A/S reported no remaining Disc Medicine position as of Q4 2023 after selling out during the quarter.
Novo Holdings A/S sold 1,090,772 Disc Medicine shares in Q4 2023, an estimated $51.2M.
Novo Holdings A/S first reported a position in Disc Medicine in Q4 2022 and held it in 4 quarters.
Novo Holdings A/S's Disc Medicine position peaked at $51.2M in Q3 2023.
112 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2023.

Based on Novo Holdings A/S's 13F filing for Q4 2023, filed 14 Feb 2024.